T 0688/14 (Recombinant Factor VIII production/OCTAPHARMA) of 24.07.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T068814.20190724
- Date of decision
- 24 July 2019
- Case number
- T 0688/14
- Petition for review of
- -
- Application number
- 06725404.5
- IPC class
- C12P 21/02C07K 14/755
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD FOR ISOLATION OF RECOMBINANTLY PRODUCED PROTEINS
- Applicant name
- Octapharma AG
- Opponent name
- Novo Nordisk A/S
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Main request - novelty (no)
Auxiliary request - added subject-matter (no), novelty (yes), inventive step (no); - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.